口服利尿剂心衰患者利尿反应预测方程的验证
本研究在MDR与TRANSFORM-Mechanism两个心衰队列中验证利尿反应预测方程(NRPE)对口服袢利尿剂反应的评估能力。提示服药后2小时尿样结合NRPE可快速准确评估口服利尿剂反应。
要点
- 口服袢利尿剂后2小时尿样结合NRPE可准确识别利尿反应不良。
- NRPE对口服利尿剂的预测效能与既往静脉验证性能相似。
- 患者自评利尿反应准确性差,不应替代客观评估。
核心结论
- 口服利尿剂后2小时尿样结合NRPE可快速准确评估心衰患者的利钠反应。
研究设计与样本
- 在两个接受口服袢利尿剂的心衰队列(MDR与TRANSFORM-Mechanism)中评估NRPE。
- 受试者服用平日口服利尿剂后接受监督下定时尿液收集,含1小时与2小时点尿样本。
- 利尿反应不良定义为研究访视期间累计尿钠< 50 mmol。
主要发现
- MDR队列含237例患者的318次口服利尿剂给药,NRPE预测利尿反应不良的AUC为.87(95%CI .83-.91)。
- NRPE对口服利尿剂的准确性与既往验证的静脉NRPE性能相似(P = .16)。
- 患者自评利尿反应的AUC为.57(95%CI .44-.70),显著差于口服NRPE(P < .001)。
- TRANSFORM-Mechanism队列110次给药中NRPE的AUC为.89(95%CI .80-1.0)。
关键数值与推荐
- 利尿反应不良判定标准:研究访视期间累计尿钠< 50 mmol。
- NRPE预测利尿反应不良的AUC:MDR队列.87(95%CI .83-.91),TRANSFORM-Mechanism队列.89(95%CI .80-1.0)。
- 患者自评利尿反应AUC为.57(95%CI .44-.70)。
临床怎么用
- 对口服袢利尿剂的心衰患者,可在服药后2小时采集尿样并用NRPE评估利尿反应。
- 不宜仅凭患者自评尿量判断利尿反应,应结合客观指标。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND AIMS: Limited data are available to assess oral diuretic response in outpatients with heart failure (HF). The natriuretic response prediction equation (NRPE) predicts natriuresis following a loop diuretic dose using a urine sample 2 h after the dose and was validated to accurately predict intravenous diuretic response. The primary aim was to validate the NRPE's assessment of oral diuretic response in patients with HF. METHODS: The NRPE was evaluated in two HF patient cohorts receiving oral loop diuretics: Mechanisms of Diuretic Resistance (MDR) and TRANSFORM-Mechanism. Participants received their home oral loop diuretic followed by a supervised timed urine collection including spot urine samples at 1 and 2 h. Patients quantified their self-assessed diuretic response (urine volume) via a standardized survey. A poor diuretic response was defined as cumulative natriuresis < 50 mmol over the study visit. RESULTS: The MDR cohort included 318 oral diuretic administrations from 237 patients. The NRPE predicted a poor natriuretic response with an area under the curve (AUC) of .87 [95% confidence interval (CI) .83-.91] and similar accuracy to the previously validated intravenous NRPE performance (P = .16). Patient's ability to self-estimate their diuretic response was poor with an AUC of .57 (95% CI .44-.70) and significantly worse than the oral NRPE (P < .001). In TRANSFORM-Mechanism (110 oral diuretic administrations), the NRPE had similar operating characteristics (AUC .89, 95% CI .80-1.0) for poor diuretic response. CONCLUSIONS: Natriuretic response to an oral diuretic can be rapidly and accurately assessed with a urine sample collected 2 h after an oral diuretic dose and the NRPE.
引用
- Ivey-Miranda, Rao, Cox, et al. Natriuretic response prediction equation for use with oral diuretics in heart failure. Eur Heart J. 2025. PMID: 40272149. doi:10.1093/eurheartj/ehaf268
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。